Silicon Valley Bank

Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Pryon is an artificial intelligence company specializing in enterprise knowledge management. Founded by Igor Jablokov in 2017, the company develops a natural language processing platform that transforms unstructured data into productive experiences, increasing efficiency with high accuracy and speed.

Troy Medicare is a pharmacy-powered Medicare Advantage company based in Charlotte, North Carolina, founded in 2019. It specializes in providing personalized Medicare health plans that leverage data and technology to enhance patient care. The company's approach focuses on empowering healthcare providers to effectively influence patient health outcomes, ensuring that individuals have access to fair and transparent health plans. By integrating pharmacies and healthcare providers into its model, Troy Medicare aims to improve health results and reward those who contribute to better patient care.

Humacyte specializes in developing human tissue-based products for regenerative medicine and vascular surgery. It creates acellular extracellular matrices using banked vascular smooth muscle cells, which are then decellularized to eliminate rejection risks. These matrices serve as off-the-shelf tissue-engineered grafts for patients requiring vascular repair or replacement.

Nasuni Corporation is a provider of enterprise cloud file storage solutions, designed to address the challenges associated with the growth of unstructured file data. Founded in 2009 and headquartered in Boston, Massachusetts, with additional offices in the United Kingdom and North Carolina, Nasuni offers its proprietary Nasuni UniFS, a cloud-native global file system that consolidates and protects file data in an easily expandable cloud infrastructure. This platform serves as a modern replacement for traditional network-attached storage and file server systems, simplifying IT administration by eliminating the need for complex legacy backup and disaster recovery solutions. Nasuni’s services cater to various industries, including architecture, engineering, healthcare, manufacturing, and financial services, enabling organizations to efficiently store, share, and access their files from anywhere, whether in the office or remotely.

Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Samanage Ltd. is a cloud-based service management platform that focuses on enhancing organizational efficiency and employee productivity. Established in 2007 and headquartered in Cary, North Carolina, the company provides a range of IT management solutions, including IT service management, IT service desk capabilities, and IT audits. Samanage's software is designed to simplify complex tasks and automate routine processes, allowing organizations, particularly in the healthcare and financial sectors, to deliver faster and more effective services. The platform is recognized for its high user ratings and reviews, reflecting its commitment to empowering clients with insights that drive productivity. Samanage operates additional offices in several global locations, including San Francisco, London, Rotterdam, Netanya, and Paddington, and became a subsidiary of SolarWinds Corporation in 2019.

Appia is a prominent mobile user acquisition network that specializes in delivering mobile app downloads to over 1 billion users across 200 countries. The company provides a marketplace platform for mobile application developers, offering them a distribution point while enabling advertisers to acquire high-value customers. Appia's advanced technology and extensive network ensure that applications reach a large and engaged audience, maximizing app installs and profit per install for its clients. With a diverse portfolio of trusted brands, Appia has established itself as a leader in mobile app discovery. The company operates from offices in San Francisco, California, and Durham, North Carolina, along with global sales offices, and has gained recognition for its rapid growth and innovation in the mobile advertising space.

Argos Therapeutics is a biotechnology company specializing in developing immunotherapy treatments for cancer and infectious diseases. It focuses on personalized immunotherapies using its proprietary Arcelis technology platform, with product candidates including rocapuldencel-T for metastatic renal cell carcinoma and AGS-004 for HIV.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Catena Networks develops broadband access systems that enable service providers to deploy voice, data, and video services. The company's products include The CNX-5 Broadband DSL System, a card-for-card upgrade solution for Lucent SLC-5 Digital Loop Carriers and The CN1000 Broadband Loop Carrier that enables service providers to deploy integrated plain old telephone service (POTS) and digital subscriber line (DSL) services and deliver voice, data and video services over copper and fiber infrastructures. It caters to local exchange carriers, postal telephone and telegraph operators, and other service providers. The company was founded in 1998 and is based in California, US with an additional office in Morrisville, North Carolina.